GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Dividend Yield %

Chordia Therapeutics (TSE:190A) Dividend Yield % : 0.00% (As of Mar. 29, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Dividend Yield %?

As of today (2025-03-29), the Trailing Annual Dividend Yield of Chordia Therapeutics is 0.00%.

The historical rank and industry rank for Chordia Therapeutics's Dividend Yield % or its related term are showing as below:

TSE:190A's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.4
* Ranked among companies with meaningful Dividend Yield % only.

Chordia Therapeutics's Dividend Payout Ratio for the three months ended in Aug. 2024 was 0.00.

As of today (2025-03-29), the Forward Dividend Yield % of Chordia Therapeutics is 0.00%.

Chordia Therapeutics's Dividends per Share for the three months ended in Aug. 2024 was 円0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Chordia Therapeutics Dividend Yield % Historical Data

The historical data trend for Chordia Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Dividend Yield % Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Dividend Yield %
- - - -

Chordia Therapeutics Quarterly Data
Aug21 Aug22 Aug23 Aug24
Dividend Yield % - - - -

Competitive Comparison of Chordia Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Chordia Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordia Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's Dividend Yield % falls into.


;
;

Chordia Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Chordia Therapeutics  (TSE:190A) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Chordia Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines